Altimmune (ALT) Change in Taxes (2017)

Altimmune's (ALT) quarterly Change in Taxes came in at -$3.2 million in Q1 2017.

Altimmune (ALT) Change in Taxes (2017) Analysis & Trends

Altimmune (ALT) has 1 years of Change in Taxes data on file, last reported at -$3.2 million in Q1 2017.

On a quarterly basis, Change in Taxes changed N/A year-over-year to -$3.2 million in Q1 2017; TTM through Dec 2025 was -$3.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.4 million, changed N/A from the prior year.
Change in Taxes for Q1 2017 stood at -$3.2 million.
Over the last five years, Change in Taxes for ALT reached as high as -$3.2 million in Q1 2017 and fell as low as -$3.2 million in Q1 2017.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-8,939.03
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Altimmune	7.96 Mn	7.96 Mn	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2017	-3.16 Mn
Mar 31, 2017	-3.16 Mn